Preoperative Management of Pheochromocytoma and Paraganglioma.

Li Ding, Qing He, Ming Liu, Fang Fang

Journal: Frontiers in endocrinology 2021;11():586795

PMID: 33117294

Abstract

["Pheochromocytoma and paraganglioma (PPGL) are rare neuroendocrine tumors, characterized by excessive release of catecholamines (CAs), and manifested as the classic triad of headaches, palpitations, profuse sweating, and a variety of other signs and symptoms. The diagnosis of PPGL requires both evidence of excessive release of CAs and anatomical localization of CA-secreting tumor. Surgery is the mainstay of treatment for all patients with PPGL unless contraindicated. However, without proper preparation, the release of excessive CAs, especially during surgery, can result in lethal cardiovascular complications. Herein, we briefly reviewed the pathogenesis of this disease, discussed the current approaches and evidence available for preoperative management, summarizing the results of the latest studies which compared the efficacies of preoperative management with or without \u03b1 adrenergic-receptor antagonists, aiming to facilitate better understanding of the preoperative management of PPGL for the physicians.",{"copyright":"Copyright \u00a9 2020 Fang, Ding, He and Liu."}]
Address: Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.